Name: Cagrilintide+Semaglutide Compound Peptide

Synonyms: CagriSema Blend, Amylin & GLP-1 Dual Pathway Weight Management Peptide Mixed CAS Registry number: Cagrilintide 1415456-99-3, Semaglutide 910463-68-2

99% Pharmaceutical-Grade Purity - Rigorously compounded lyophilized peptide for synergistic appetite control, fat loss and blood sugar balance laboratory research use. 1.Lab-Verified Fixed Ratio Vials - Precisely blended sterile lyophilized powder with 5mg Cagrilintide+5mg Semaglutide for laboratory and research applications. 2.Metabolic Synergy Benefits: Cagrilintide is long-acting amylin analog to enhance satiety and delay gastric emptying; Semaglutide acts as GLP-1 agonist to boost insulin secretion and inhibit glucagon. Two peptides work through complementary non-overlapping pathways for obesity, type 2 diabetes and metabolic syndrome research studies. 3.Third-Party HPLC/LC-MS Tested - Each batch passes strict purity and identity testing with complete COA documentation. 4.Easy Reconstitution - Quickly dissolved with bacteriostatic water for convenient laboratory research use.